// App-Quantinova.ai

P153 : The impact of seton use on clinical and patient-reported outcomes in Crohn’s disease perianal fistulas: findings from a systematic literature review

Researchers

Presenter

  • White, I

Principal Investigators

  • Karki, C

  • Geransar , P

  • Worsfold, A

  • Leisle, L

  • Junker, S

  • Fleshner, P

Medical Centers

  • Beilinson Hospital- Rabin Medical Centre, Colorectal Unit- Surgical Department, Petah Tikva, Israel

  • Takeda Pharmaceuticals USA- Inc., Global Evidence and Outcomes, Cambridge MA, United States

  • Takeda Pharmaceuticals International AG, GI Rare Medical Affairs, Zurich, Switzerland

  • M-Spective Limited, Real-World Evidence & Analytics, Cambridge, United Kingdom

  • Ingress-Health HWM GmbH an affiliate of Cytel Inc., Real World Advanced Analytics, Berlin, Germany

  • Cedars-Sinai Medical Centre, Division of Colon and Rectal, Los Angeles- California, United States

Locations

  • Israel

  • United States

  • Switzerland

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved